Despite all modern advancements in reconstructive surgery for peripheral nerve repair, recovery remains painful, frustrating, and unsatisfactory due to the absence of treatment options. Without medications or devices to support recovery after surgery for transected or severely compressed nerves, patients are often left with long term numbness, pain and loss of movement, impacting their quality of life and earning potential. Epineuron is a clinical-stage medical device company developing the first therapeutic treatment for injured peripheral nerves. The company’s lead product delivers a unique bioelectronic therapy that accelerates nerve regeneration, resulting in better and earlier overall functional recovery (movement and sensation) for patients. It’s a single-use wearable used after nerve repair surgery and has been designated a Breakthrough Device by the FDA.
Intellectual Property
Founders Fast Track is 6 week mentorship program that provides your startup with access to industry expertise, resources, networking opportunities, and skills to help you secure investment capital.
Applications are open until December 8, 2024